S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Cost of Revenue Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Cost of Revenue
-â‚©173.8B
CAGR 3-Years
-20%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Cost of Revenue
-â‚©2.1T
CAGR 3-Years
-39%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Cost of Revenue
-â‚©12.8B
CAGR 3-Years
-11%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Cost of Revenue
-â‚©16B
CAGR 3-Years
-4%
CAGR 5-Years
5%
CAGR 10-Years
N/A
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Cost of Revenue
-â‚©22.4B
CAGR 3-Years
-200%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Cost of Revenue
-â‚©10.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Cost of Revenue?
Cost of Revenue
-173.8B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Cost of Revenue amounts to -173.8B KRW.

What is ST Pharm Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-16%

Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for ST Pharm Co Ltd have been -20% over the past three years , -16% over the past five years .

Back to Top